Benitec Biopharma | 3: Initial statement of beneficial ownership of securities-10% Owner SUVRETTA CAPITAL MANAGEMENT, LLC
May 2 17:30 ET
Benitec Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Suvretta Capital Management, LLC(19.99%),Aaron Cowen(19.99%), etc.
Apr 29 16:13 ET
Benitec Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-HBM Healthcare Investments (Cayman) Ltd.(9.99%)
Apr 29 16:10 ET
Benitec Biopharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Steven M. Oliveira(8.89%),Nemean Asset Management, LLC(8.39%), etc.
Apr 29 11:50 ET
Benitec Biopharma | D: Filing D
Apr 25 16:18 ET
Benitec Biopharma | 8-K: Current report
Apr 19 06:11 ET
Benitec Biopharma | 8-K: Current report
Apr 18 08:56 ET
Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Partners, L.P.(9.99%),Adage Capital Partners GP, L.L.C.(9.99%), etc.
Apr 11 12:14 ET
Benitec Biopharma | 8-K: Current report
Mar 8 16:22 ET
Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Boston Megan
Mar 8 16:17 ET
Benitec Biopharma | 4: Statement of changes in beneficial ownership of securities-Officer Banks Jerel A.
Mar 8 16:17 ET
Benitec Biopharma | EFFECT: Others
Mar 6 06:03 ET
Benitec Biopharma | CORRESP: CORRESP
Mar 1 13:02 ET
Benitec Biopharma | UPLOAD: Others
Feb 28 13:02 ET
Benitec Biopharma | DEL AM: Others
Feb 26 09:10 ET
Benitec Biopharma | S-3: Registration statement for specified transactions by certain issuers
Feb 23 16:17 ET
Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kenneth Griffin(3.6%),Citadel Advisors LLC(3.4%), etc.
Feb 14 18:23 ET
Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Suvretta Capital Management, LLC(9.99%),Aaron Cowen(9.99%), etc.
Feb 13 23:02 ET
Benitec Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(7.0%),Janus Henderson Biotech Innovation Master Fund Ltd(7.0%)
Feb 13 10:02 ET
Benitec Biopharma | 8-K: Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update
Feb 13 08:19 ET
No Data
No Data